387 related articles for article (PubMed ID: 35176710)
1. Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19).
Zhang Q; Ling S; Hu K; Liu J; Xu JW
Biomed Pharmacother; 2022 Apr; 148():112718. PubMed ID: 35176710
[TBL] [Abstract][Full Text] [Related]
2. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
Zhu Y; Chen X; Liu X
Front Immunol; 2022; 13():838011. PubMed ID: 35309344
[TBL] [Abstract][Full Text] [Related]
3. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
[TBL] [Abstract][Full Text] [Related]
4. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
Matsuzawa Y; Kimura K; Ogawa H; Tamura K
Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
Veras FP; Pontelli MC; Silva CM; Toller-Kawahisa JE; de Lima M; Nascimento DC; Schneider AH; Caetité D; Tavares LA; Paiva IM; Rosales R; Colón D; Martins R; Castro IA; Almeida GM; Lopes MIF; Benatti MN; Bonjorno LP; Giannini MC; Luppino-Assad R; Almeida SL; Vilar F; Santana R; Bollela VR; Auxiliadora-Martins M; Borges M; Miranda CH; Pazin-Filho A; da Silva LLP; Cunha LD; Zamboni DS; Dal-Pizzol F; Leiria LO; Siyuan L; Batah S; Fabro A; Mauad T; Dolhnikoff M; Duarte-Neto A; Saldiva P; Cunha TM; Alves-Filho JC; Arruda E; Louzada-Junior P; Oliveira RD; Cunha FQ
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32926098
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin-aldosterone system and COVID-19 infection.
Alexandre J; Cracowski JL; Richard V; Bouhanick B;
Ann Endocrinol (Paris); 2020 Jun; 81(2-3):63-67. PubMed ID: 32370986
[TBL] [Abstract][Full Text] [Related]
7. Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature.
Masso-Silva JA; Moshensky A; Lam MTY; Odish MF; Patel A; Xu L; Hansen E; Trescott S; Nguyen C; Kim R; Perofsky K; Perera S; Ma L; Pham J; Rolfsen M; Olay J; Shin J; Dan JM; Abbott RK; Ramirez S; Alexander TH; Lin GY; Fuentes AL; Advani I; Gunge D; Pretorius V; Malhotra A; Sun X; Duran J; Hepokoski M; Crotty S; Coufal NG; Meier A; Crotty Alexander LE
Clin Infect Dis; 2022 Feb; 74(3):479-489. PubMed ID: 33988226
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Diseases: Consider Netosis.
Mozzini C; Pagani M
Curr Probl Cardiol; 2022 Oct; 47(10):100929. PubMed ID: 34315622
[TBL] [Abstract][Full Text] [Related]
9. Drugs acting on renin angiotensin system and use in ill patients with COVID-19.
Alexandre J; Cracowski JL; Richard V; Bouhanick B;
Therapie; 2020; 75(4):319-325. PubMed ID: 32553503
[TBL] [Abstract][Full Text] [Related]
10. The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review.
Naveed H; Elshafeey A; Al-Ali D; Janjua E; Nauman A; Kawas H; Kaul R; Saed Aldien A; Elshazly MB; Zakaria D
J Clin Pharmacol; 2021 Aug; 61(8):987-1000. PubMed ID: 33635546
[TBL] [Abstract][Full Text] [Related]
11. COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.
Makatsariya A; Slukhanchuk E; Bitsadze V; Khizroeva J; Tretyakova M; Tsibizova V; Dobryakov A; Elalamy I; Gris JC
J Perinat Med; 2020 Nov; 48(9):985-994. PubMed ID: 32739908
[TBL] [Abstract][Full Text] [Related]
12. Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis.
Chu C; Zeng S; Hasan AA; Hocher CF; Krämer BK; Hocher B
Br J Clin Pharmacol; 2021 Jun; 87(6):2475-2492. PubMed ID: 33217033
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
[TBL] [Abstract][Full Text] [Related]
14. The central role of neutrophil extracellular traps (NETs) and by-products in COVID-19 related pulmonary thrombosis.
Li S; Wang H; Shao Q
Immun Inflamm Dis; 2023 Aug; 11(8):e949. PubMed ID: 37647446
[TBL] [Abstract][Full Text] [Related]
15. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
Zemlin AE; Wiese OJ
Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.
Tomar B; Anders HJ; Desai J; Mulay SR
Cells; 2020 Jun; 9(6):. PubMed ID: 32498376
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H
Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
